Switzerland's competition commission this week became the first public regulator to confirm evidence of suspected rigging, while authorities in Hong Kong and Great Britain disclosed new moves in their investigations.
Separately, an amended U.S. federal court lawsuit filed by municipal retirement systems and financial funds added new allegations against 12 major banks whose traders are suspected of colluding to boost their own profits by rigging currency rates.
The developments prompt comparisons with the separate investigation of Libor, the London Interbank Offered Rate used to set rates on trillions of dollars in mortgages, loans and credit cards. U.S. and British authorities so far have fined four global banks and the world's largest inter-dealer broker more than $3.6 billion collectively for rigging the financial benchmark.
Best Internet Stocks To Watch For 2015: iShares MSCI Austria Capped ETF (EWO)
iShares MSCI Austria Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Austrian market, as measured by the MSCI Austria Index (the Index). The Index seeks to measure the performance of the Austrian equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Tom Aspray]
This is quite a bit better than the 9.2% gain of the iShares MSCI Italy (EWI) or the 8.9% rise in the iShares MSCI Austria (EWO). All three have done significantly better than the Spyder Trust (SPY), which is up 3.6%. The French and German country ETFs have not yet moved above their late 2013 highs.
Top 5 Heal Care Companies To Invest In 2014: Dyax Corp.(DYAX)
Dyax Corp., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel biotherapeutics for unmet medical needs in the United States. The company utilizes its proprietary drug discovery technology, known as phage display, to identify antibody, small protein, and peptide compounds. It markets KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. Dyax Corp. also provides KALBITOR Access program, which offers treatment support service for patients with HAE and their healthcare providers. In addition, the company is developing a pipeline of 17 product candidates, including 4 product candidates in Phase III clinical trial, 4 product candidates in Phase II clinical trial, and 9 product candidates in Phase 1 clinical trial for the treatment of atherosclerosis, multiple sclerosis, and oncology diseases. Further, it provides library licenses to use its phage display libr aries in connection with their internal therapeutic development programs; performs funded research for various collaborators; and offers patent licenses to other biopharmaceutical and pharmaceutical companies to use its phage display patents to discover and develop biologic compounds for use in specified fields. The company has strategic partnership agreement with Defiante Farmaceutica S.A. to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other therapeutic indications in Europe, North Africa, the Middle East, and Russia; an agreement with CMIC Co., Ltd to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other angioedema indications in Japan; and an license and collaboration agreement with Cubist Pharmaceuticals, Inc. to develop and commercialize the formulation of ecallantide for the reduction of blood loss during surgery in North America and Europe. Dyax Corp. was founded in 1989 and is headquartered in Cambri dge, Massachusetts.
Advisors' Opinion:- [By Brian Orelli]
Dyax (NASDAQ: DYAX ) and its investors will also be keeping a close eye on trebananib's development. The biotech helped Amgen discover trebananib and is due milestone payments for successful development of the drug.
- [By Jake L'Ecuyer]
Dyax (NASDAQ: DYAX) shares tumbled 9.85 percent to $9.15 after the company priced 8 million shares at $9.25 per share.
Raptor Pharmaceuticals (NASDAQ: RPTP) was down, falling 20.45 percent to $11.77 after the company reported Q4 results. Raptor Pharmaceutical posted a Q4 loss of $0.20 per share, versus the projected loss of $0.16 per share.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
In trading on Tuesday, healthcare shares were relative leaders, up on the day by about 1.35 percent. Meanwhile, top gainers in the sector included Allergan (NYSE: AGN), up 15.7 percent, and Dyax (NASDAQ: DYAX), up 12.5 percent. Energy shares dropped around 0.06 percent in today's trading. - [By Jake L'Ecuyer]
Dyax (NASDAQ: DYAX) shares tumbled 10.39 percent to $9.10 after the company priced 8 million shares at $9.25 per share.
Raptor Pharmaceuticals (NASDAQ: RPTP) was down, falling 10.04 percent to $13.31 after the company reported Q4 results. Raptor Pharmaceutical posted a Q4 loss of $0.20 per share, versus the projected loss of $0.16 per share.
Top 5 Heal Care Companies To Invest In 2014: Avino Silver & Gold Mines Ltd (ASM)
Avino Silver & Gold Mines Ltd. (Avino) is a natural resource company, primarily engaged in the acquisition, exploration and development of natural resource properties. The Company�� principal business activities include the exploration of a mineral property located in the State of Durango, Mexico and other mineral properties in Canada, specifically British Columbia and the Yukon Territory. The Company is focused on silver and gold exploration. As of December 31, 2011, the Company explored five silver and gold projects in Canada and Mexico. All of the Company�� mineral property interests in Canada are wholly owned by the Company. In Mexico, the Company has a 99.28% interest in Cia Minera, a Mexican company, which is involved in the mining of commercial ores and resource exploration and development, including the operation of the Avino Mine. Cia Minera is not involved with any exploration activities in Canada. Advisors' Opinion:- [By abirk]
Spirit's profits are signs of steady growth. Since 2010, Annual passenger revenue and net income have both increased steadily. Spirit generated 24.4% growth in revenue passenger miles (RPM), while the available seat miles (ASM), and grew 24.8%. On the other hand, Delta's mainland division had 8.6 million RPM. �On a revenue basis, Spirit is equivalent to about 3.2% of the total revenue of the combined Delta and US Airways, now part of American Airlines Group (AAL).
Top 5 Heal Care Companies To Invest In 2014: ConAgra Foods Inc.(CAG)
ConAgra Foods, Inc. operates as a food company primarily in North America. It operates in two segments, Consumer Foods and Commercial Foods. The Consumer Foods segment provides branded, private label, and customized food products, which are sold in various retail and foodservice channels. It offers products in various categories, such as meals, entrees, condiments, sides, snacks, and desserts in frozen, refrigerated, and shelf-stable temperature classes. This segment?s principal brands include Alexia, ACT II, Banquet, Blue Bonnet, Chef Boyardee, DAVID, Egg Beaters, Healthy Choice, Hebrew National, Hunt?s, Marie Callender?s, Orville Redenbacher?s, PAM, Peter Pan, Reddi-wip, Slim Jim, Snack Pack, Swiss Miss, Van Camp?s, and Wesson. The Commercial Foods segment provides commercially branded foods and ingredients that are sold to foodservice, food manufacturing, and industrial customers. Its primary products consist of specialty potato products, milled grain ingredients, a ran ge of vegetable products, seasonings, blends, and flavors. This segment sells products under brands, such as ConAgra Mills, Lamb Weston, and Spicetec Flavors & Seasonings. The company was founded in 1919 and is headquartered in Omaha, Nebraska.
Advisors' Opinion:- [By Suravi Thacker]
This is what is understood and followed continuously by the packaged food retailer ConAgra Foods (CAG). The company has been performing well, owing to its expansion in the low priced private label products which are faring well since it is lighter on consumers��pockets. However, unfavorable weather conditions forced the food company to register a dull quarter. Let us understand the company better.
- [By Nicole Seghetti]
Private-label pressures
Regardless, private labels are becoming a bigger problem for companies such as Kraft and, to a lesser extent, Mondelez. According to an industry profile compiled by First Research, these brands typically cost 20% to 40% less than name-brand products. Couple that with the fact that more consumers are ditching big brands, and we can easily see why ConAgra (NYSE: CAG ) , Cott (NYSE: COT ) , and others are continually strengthening their private-label positions. - [By Dan Caplinger]
One area where Whole Foods could see huge promise is in the rise of private-label brands. In the conventional food space, ConAgra's (NYSE: CAG ) buyout of Ralcorp Holdings, which closed in late January, upped the ante for private-label sales. Brand-name food producers like Kellogg and General Mills now find themselves on the defensive against lower-priced alternatives that compete well not only on price but also on quality. Yet Whole Foods has taken advantage of the trend to come out with its own private-label offerings, which have the potential to boost its margins even further.
- [By Lawrence Meyers]
But look, the point of a defensive stock is that in a bad economy it shouldn�� fall as much as the overall market. At 25x earnings, COST is already so overvalued that it eliminates that protection.
ConAgra Foods (CAG)On a list of consumer staples, you can always expect food to be near the top.
No comments:
Post a Comment